封面
市場調查報告書
商品編碼
2067751

全球晶片實驗室組件市場規模、佔有率、趨勢和成長分析報告(2026-2034)

Global Lab-on-a-Chip Component Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球晶片實驗室組件市場預計將從2025年的77.4億美元成長至2034年的181.5億美元,2026年至2034年的複合年成長率(CAGR)為9.93%。這個市場快速擴張的原因在於醫療和研究領域對小型化診斷和分析儀器的需求不斷成長。晶片實驗室組件在醫療診斷、生物技術和藥物研發領域具有巨大的價值,能夠實現更快的檢測速度、更少的檢體消耗和更高的診斷準確性。即時檢測技術的日益普及是推動全球市場成長的主要因素。

微流體、生物感測器和奈米技術的進步是推動該產業發展的主要動力。醫療機構和研究機構擴大使用晶片實驗室系統進行疾病檢測、藥物研發和基因分析。感染疾病的蔓延和對攜帶式診斷解決方案日益成長的需求,進一步加速了已開發國家和新興市場對該行業的擴張。

隨著個人化醫療和數位醫療在全球範圍內不斷發展,市場前景依然十分光明。生物醫學研究投入的增加以及人工智慧(AI)在診斷平台的應用,可望提升檢測的效率和可靠性。醫療基礎設施的擴建和對快速診斷技術日益成長的需求,預計將為製造商和技術提供者創造巨大的長期成長機會。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節對市場進行了清晰的說明,包括關鍵定義、分類以及當前行業格局的概述。

市場動態:對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業進行了詳細評估,包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測:本部分提供基於數據的市場規模和成長模式預測,預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析,以識別預期的未來趨勢。

區域分析:這包括對主要地理區域的市場表現進行全面檢驗,確定高成長地區和區域趨勢,以更深入地了解區域市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的報告客製化服務,以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察,從而更有效地支援策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球晶片實驗室組件市場:依產品和服務分類

  • 市場分析、洞察與預測
  • 試劑和耗材
  • 裝置
  • 軟體服務

第5章 全球晶片實驗室組件市場:依技術分類

  • 市場分析、洞察與預測
  • 微流體技術
  • 光學技術
  • 電化學技術
  • 其他

第6章 全球晶片實驗室組件市場:依應用分類

  • 市場分析、洞察與預測
  • 臨床診斷
  • 藥物發現與開發
  • 其他

第7章 全球晶片實驗室組件市場:依最終用途分類

  • 市場分析、洞察與預測
  • 學術研究機構
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 其他

第8章 全球晶片實驗室組件市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher ScientificInc
    • IlluminaInc
    • Danaher
    • Merck KGaA
    • Abbott Laboratories
    • QIAGEN
    • Agilent Technologies
    • Standard BioTools
    • RevvityInc
    • Bio-Rad Laboratories
    • F. Hoffmann-La Roche AG
    • Becton, Dickinson And Company
    • Fluidigm Corporation
    • PerkinElmer
    • IDEX Corporation
簡介目錄
Product Code: VMR112118420

The global lab-on-a-chip component market size is expected to reach USD 18.15 Billion in 2034 from USD 7.74 Billion in 2025, growing at a CAGR of 9.93 during 2026-2034.This market is expanding rapidly due to the increasing demand for miniaturized diagnostic and analytical devices in healthcare and research applications. Lab-on-a-chip components enable faster testing, reduced sample consumption, and improved diagnostic accuracy, making them highly valuable in medical diagnostics, biotechnology, and pharmaceutical research. Rising adoption of point-of-care testing technologies is significantly contributing to market growth worldwide.

Technological advancements in microfluidics, biosensors, and nanotechnology are major drivers supporting the development of the industry. Healthcare providers and research laboratories are increasingly utilizing lab-on-a-chip systems for disease detection, drug discovery, and genetic analysis. The growing prevalence of infectious diseases and rising demand for portable diagnostic solutions are further accelerating market expansion across developed and emerging economies.

Future prospects for the market remain highly positive as personalized medicine and digital healthcare continue to evolve globally. Increasing investments in biomedical research and the integration of artificial intelligence into diagnostic platforms are expected to improve testing efficiency and reliability. Expanding healthcare infrastructure and rising demand for rapid diagnostic technologies are likely to create significant long-term growth opportunities for manufacturers and technology providers.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

By Technology

  • Microfluidics Technology
  • Optical Technology
  • Electrochemical Technology
  • Others

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Others

By End Use

  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher, Merck KGaA, Abbott Laboratories, QIAGEN, Agilent Technologies, Standard BioTools, Revvity, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Fluidigm Corporation, PerkinElmer, IDEX Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product & Service
  • 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Microfluidics Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Optical Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Electrochemical Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product & Service
    • 8.2.2 By Technology
    • 8.2.3 By Application
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product & Service
    • 8.3.2 By Technology
    • 8.3.3 By Application
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product & Service
    • 8.4.2 By Technology
    • 8.4.3 By Application
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product & Service
    • 8.5.2 By Technology
    • 8.5.3 By Application
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product & Service
    • 8.6.2 By Technology
    • 8.6.3 By Application
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL LAB-ON-A-CHIP COMPONENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher ScientificInc
    • 10.2.2 IlluminaInc
    • 10.2.3 Danaher
    • 10.2.4 Merck KGaA
    • 10.2.5 Abbott Laboratories
    • 10.2.6 QIAGEN
    • 10.2.7 Agilent Technologies
    • 10.2.8 Standard BioTools
    • 10.2.9 RevvityInc
    • 10.2.10 Bio-Rad Laboratories
    • 10.2.11 F. Hoffmann-La Roche AG
    • 10.2.12 Becton, Dickinson And Company
    • 10.2.13 Fluidigm Corporation
    • 10.2.14 PerkinElmer
    • 10.2.15 IDEX Corporation